REAZYN DEMOSS: Open Payments
NPI 1205437647 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 93 payments from 14 companies in 2025. Trend: 2023 $1,186 · 2024 $1,286 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $437 |
| ABBVIE INC. | 31 | $288 |
| Novo Nordisk Inc | 16 | $226 |
| Lilly USA, LLC | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: AIRSUPRA, BREZTRI, Ozempic, UBRELVY, VRAYLAR, MOUNJARO, CAPLYTA, QULIPTA.
Industry payments across TN — which companies pay providers there.
